Boston Scientific Corporation

BSX

US1011371077

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 04:00:05 2024-04-23 pm EDT			5-day change	1st Jan Change
68.99 ^USD	+1.43%		+1.28%	+19.34%

05:25pm	Edwards Lifesciences Corporation: The story continues
Apr. 19	Nephron Research Raises Boston Scientific's Price Target to $80 From $75	MT

Boston Scientific Corporation Provides Earnings Guidance for the Third Quarter of 2021

September 22, 2021 at 08:30 am EDT

Boston Scientific Corporation provided earnings guidance for the third quarter of 2021. For the third quarter, the company expected EPS guidance of $0.39 to $0.41.

Latest news about Boston Scientific Corporation

Edwards Lifesciences Corporation: The story continues	11:25am
Nephron Research Raises Boston Scientific's Price Target to $80 From $75	Apr. 19	MT
FDA classifies recall of Boston Scientific device as 'most serious'	Apr. 17	RE
FDA classifies recall of Boston Scientific device to treat hemorrhaging as 'most serious'	Apr. 17	RE
Baird Adjusts Boston Scientific Price Target to $79 From $72	Apr. 17	MT
Integer Holdings to Benefit from Pulsed Field Ablation Market Growth, BofA Says	Apr. 15	MT
Truist Securities Adjusts Boston Scientific Price Target to $79 From $73, Buy Rating Kept	Apr. 15	MT
BTIG Adjusts Boston Scientific's Price Target to $74 From $72	Apr. 15	MT
RBC Raises Price Target on Boston Scientific to $78 From $70, Keeps Outperform Rating	Apr. 15	MT
Penumbra, Inc. : The underdog in healthcare	Apr. 11
Nectero Medical LLC announced that it has received $96 million in funding from Boston Scientific Corporation, NVP Associates, LLC, BioStar Ventures LLC, Cadence Healthcare Ventures, Llc, Aphelion Capital, LLC and other investors	Apr. 10	CI
Boston Scientific Starts Study of Software Module, Catheter for Treatment of Atrial Fibrillation	Apr. 08	MT
Boston Scientific, Axonics Receive FTC Second Request on Merger Deal	Apr. 04	MT
Boston Scientific, Axonics Merger Prompts FTC to Request Additional Information	Apr. 04	DJ
FTC seeks additional information for Boston Scientific's $3.7 bln Axonics deal	Apr. 04	RE
Argus Raises Boston Scientific's Price Target to $80 From $69, Keeps Buy Rating	Apr. 03	MT
Citigroup Adjusts Price Target on Boston Scientific to $79 From $71, Keeps Buy Rating	Apr. 03	MT
Boston Scientific Insider Sold Shares Worth $1,133,069, According to a Recent SEC Filing	Apr. 03	MT
Boston Scientific Insider Sold Shares Worth $477,777, According to a Recent SEC Filing	Apr. 03	MT
Scivita Medical Technology Co., Ltd. and Boston Scientific Corporation Sign an Expanded Strategic Cooperation Arrangement	Mar. 25	CI
Axonics Wins Shareholder Approval of Merger With Boston Scientific	Mar. 22	MT
Boston Scientific Insider Sold Shares Worth $963,930, According to a Recent SEC Filing	Mar. 20	MT
TD Cowen Raises Boston Scientific's Price Target to $77 From $65, Maintains Outperform Rating	Mar. 07	MT
Transcript : Boston Scientific Corporation Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-06-2024 09:10 AM	Mar. 06
Boston Scientific Insider Sold Shares Worth $463,322, According to a Recent SEC Filing	Mar. 05	MT

Chart Boston Scientific Corporation

Duration

Period

More charts

Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%); - endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ; - neuromodulation (2%). The United States account for 59.2% of net sales.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-04-23 - Q1 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Boston Scientific Corporation

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

68.02 USD

Average target price

73.4 USD

Spread / Average Target

+7.91%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
BOSTON SCIENTIFIC CORPORATION	+19.34%	99.98B
THERMO FISHER SCIENTIFIC	+8.35%	209B
DANAHER CORPORATION	+9.41%	175B
INTUITIVE SURGICAL, INC.	+11.75%	131B
SIEMENS HEALTHINEERS AG	-0.84%	61.12B
EDWARDS LIFESCIENCES CORPORATION	+15.08%	52.34B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-2.10%	46.5B
AGILENT TECHNOLOGIES, INC.	+0.10%	39.24B
GE HEALTHCARE TECHNOLOGIES INC.	+11.50%	38.47B
RESMED, INC.	+7.11%	26.49B

Other Advanced Medical Equipment & Technology